Press Releases

Jan 11 2007

The recommended improvements to the Prescription Drug User Fee Act (PDUFA) announced today by the Food and Drug Administration (FDA) will allow continued enhancement of FDA’s post-market safety capacity and help ensure careful, timely and transparent review of new drugs and biologics, said the Biotechnology Industry Organization (BIO).

Dec 13 2006

BIO President and CEO Jim Greenwood today commented on reports that the Securities and Exchange Commission (SEC) will begin the process of easing auditing standards for small, publicly traded companies.